1. Daniels, B.P. et al. The Nucleotide Sensor ZBP1 and Kinase RIPK3 Induce the Enzyme IRG1 to Promote an Antiviral Metabolic State in Neurons. Immunity 50, 64-76 e64 (2019).
2. Nair, S. et al. Irg1 expression in myeloid cells prevents immunopathology during M. tuberculosis infection. J Exp Med 215, 1035-1045 (2018).
3. Lee, C.G., Jenkins, N.A., Gilbert, D.J., Copeland, N.G. & O'Brien, W.E. Cloning and analysis of gene regulation of a novel LPS-inducible cDNA. Immunogenetics 41, 263-270 (1995).
4. Michelucci, A. et al. Immune-responsive gene 1 protein links metabolism to immunity by catalyzing itaconic acid production. Proc Natl Acad Sci U S A 110, 7820-7825 (2013).
5. Ackermann, W.W. & Potter, V.R. Enzyme inhibition in relation to chemotherapy. Proc Soc Exp Biol Med 72, 1-9 (1949).
6. Lampropoulou, V. et al. Itaconate Links Inhibition of Succinate Dehydrogenase with Macrophage Metabolic Remodeling and Regulation of Inflammation. Cell Metab 24, 158-166 (2016).
7. Cordes, T. et al. Immunoresponsive Gene 1 and Itaconate Inhibit Succinate Dehydrogenase to Modulate Intracellular Succinate Levels. J Biol Chem 291, 14274-14284 (2016).
8. Mills, E.L. et al. Itaconate is an anti-inflammatory metabolite that activates Nrf2 via alkylation of KEAP1. Nature 556, 113-117 (2018).
9. Bambouskova, M. et al. Electrophilic properties of itaconate and derivatives regulate the IkappaBzeta-ATF3 inflammatory axis. Nature 556, 501-504 (2018).
10. Qin, W. et al. S-glycosylation-based cysteine profiling reveals regulation of glycolysis by itaconate. Nature chemical biology 15, 983-991 (2019).
11. Hu, L. et al. Crystal structure of TET2-DNA complex: insight into TET-mediated 5mC oxidation. Cell 155, 1545-1555 (2013).
12. Chowdhury, R. et al. The oncometabolite 2-hydroxyglutarate inhibits histone lysine demethylases. EMBO Rep 12, 463-469 (2011).
13. Xu, W. et al. Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of alpha-ketoglutarate-dependent dioxygenases. Cancer cell 19, 17-30 (2011).
14. Seim, G.L. et al. Two-stage metabolic remodelling in macrophages in response to lipopolysaccharide and interferon-gamma stimulation. Nature metabolism 1, 731-742 (2019).
15. Liu, P.S. et al. alpha-ketoglutarate orchestrates macrophage activation through metabolic and epigenetic reprogramming. Nature immunology 18, 985-994 (2017).
16. Xiao, M. et al. Inhibition of alpha-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors. Genes Dev 26, 1326-1338 (2012).
17. O'Neill, L.A.J. & Artyomov, M.N. Itaconate: the poster child of metabolic reprogramming in macrophage function. Nat Rev Immunol 19, 273-281 (2019).
18. Zhang, Q. et al. Tet2 is required to resolve inflammation by recruiting Hdac2 to specifically repress IL-6. Nature 525, 389-393 (2015).
19. Wang, Y. et al. WT1 recruits TET2 to regulate its target gene expression and suppress leukemia cell proliferation. Molecular cell 57, 662-673 (2015).
20. Yamamoto, M. et al. Regulation of Toll/IL-1-receptor-mediated gene expression by the inducible nuclear protein IkappaBzeta. Nature 430, 218-222 (2004).
21. Miyake, T. et al. IkappaBzeta is essential for natural killer cell activation in response to IL-12 and IL-18. Proc Natl Acad Sci U S A 107, 17680-17685 (2010).
22. Okamoto, K. et al. IkappaBzeta regulates T(H)17 development by cooperating with ROR nuclear receptors. Nature 464, 1381-1385 (2010).
23. Johansen, C. et al. IkappaBzeta is a key driver in the development of psoriasis. Proc Natl Acad Sci U S A 112, E5825-5833 (2015).
24. Alexander, E. et al. IkappaBzeta is a regulator of the senescence-associated secretory phenotype in DNA damage- and oncogene-induced senescence. J Cell Sci 126, 3738-3745 (2013).
25. Xu, H. et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 112, 1821-1830 (2003).
26. Nagarsheth, N., Wicha, M.S. & Zou, W. Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy. Nat Rev Immunol 17, 559-572 (2017).
27. Liu, T., Zhang, L., Joo, D. & Sun, S.C. NF-kappaB signaling in inflammation. Signal transduction and targeted therapy 2 (2017).
28. Rampal, R. et al. DNA hydroxymethylation profiling reveals that WT1 mutations result in loss of TET2 function in acute myeloid leukemia. Cell Rep 9, 1841-1855 (2014).
29. Ichiyama, K. et al. The methylcytosine dioxygenase Tet2 promotes DNA demethylation and activation of cytokine gene expression in T cells. Immunity 42, 613-626 (2015).
30. Ma, S. et al. Epigenetic regulator CXXC5 recruits DNA demethylase Tet2 to regulate TLR7/9-elicited IFN response in pDCs. J Exp Med 214, 1471-1491 (2017).
31. Xu, Y.P. et al. Tumor suppressor TET2 promotes cancer immunity and immunotherapy efficacy. J Clin Invest 130, 4316-4331 (2019).
32. Yamazaki, S., Muta, T., Matsuo, S. & Takeshige, K. Stimulus-specific induction of a novel nuclear factor-kappaB regulator, IkappaB-zeta, via Toll/Interleukin-1 receptor is mediated by mRNA stabilization. J Biol Chem 280, 1678-1687 (2005).
33. Link, V.M. et al. Analysis of Genetically Diverse Macrophages Reveals Local and Domain-wide Mechanisms that Control Transcription Factor Binding and Function. Cell 173, 1796-1809 e1717 (2018).
34. Zhao, Z. et al. The catalytic activity of TET2 is essential for its myeloid malignancy-suppressive function in hematopoietic stem/progenitor cells. Leukemia 30, 1784-1788 (2016).
35. Ye, D., Guan, K.L. & Xiong, Y. Metabolism, Activity, and Targeting of D- and L-2-Hydroxyglutarates. Trends Cancer 4, 151-165 (2018).
36. Ryan, D.G. et al. Coupling Krebs cycle metabolites to signalling in immunity and cancer. Nature metabolism 1, 16-33 (2019).
37. Arts, R.J. et al. Glutaminolysis and Fumarate Accumulation Integrate Immunometabolic and Epigenetic Programs in Trained Immunity. Cell Metab 24, 807-819 (2016).
38. Lio, C.J., Yuita, H. & Rao, A. Dysregulation of the TET family of epigenetic regulators in lymphoid and myeloid malignancies. Blood 134, 1487-1497 (2019).
39. Jaiswal, S. & Libby, P. Clonal haematopoiesis: connecting ageing and inflammation in cardiovascular disease. Nat Rev Cardiol 17, 137-144 (2020).
40. Cook, E.K., Luo, M. & Rauh, M.J. Clonal hematopoiesis and inflammation: Partners in leukemogenesis and comorbidity. Exp Hematol 83, 85-94 (2020).
41. Chen, M. et al. Itaconate is an effector of a Rab GTPase cell-autonomous host defense pathway against Salmonella. Science 369, 450-455 (2020).
42. Basler, T., Jeckstadt, S., Valentin-Weigand, P. & Goethe, R. Mycobacterium paratuberculosis, Mycobacterium smegmatis, and lipopolysaccharide induce different transcriptional and post-transcriptional regulation of the IRG1 gene in murine macrophages. J Leukoc Biol 79, 628-638 (2006).
43. Preusse, M., Tantawy, M.A., Klawonn, F., Schughart, K. & Pessler, F. Infection- and procedure-dependent effects on pulmonary gene expression in the early phase of influenza A virus infection in mice. BMC Microbiol 13, 293 (2013).
44. Cho, H. et al. Differential innate immune response programs in neuronal subtypes determine susceptibility to infection in the brain by positive-stranded RNA viruses. Nat Med 19, 458-464 (2013).
45. Smith, J. et al. Systems analysis of immune responses in Marek's disease virus-infected chickens identifies a gene involved in susceptibility and highlights a possible novel pathogenicity mechanism. J Virol 85, 11146-11158 (2011).
46. Safronova, A. et al. Alarmin S100A11 initiates a chemokine response to the human pathogen Toxoplasma gondii. Nat Immunol 20, 64-72 (2019).
47. Li, Y. et al. Immune responsive gene 1 (IRG1) promotes endotoxin tolerance by increasing A20 expression in macrophages through reactive oxygen species. J Biol Chem 288, 16225-16234 (2013).
48. Hall, C.J. et al. Epidermal cells help coordinate leukocyte migration during inflammation through fatty acid-fuelled matrix metalloproteinase production. Nat Commun 5, 3880 (2014).
49. Sun, K.A. et al. Endogenous itaconate is not required for particulate matter-induced NRF2 expression or inflammatory response. Elife 9 (2020).
50. Weiss, J.M. et al. Itaconic acid mediates crosstalk between macrophage metabolism and peritoneal tumors. J Clin Invest 128, 3794-3805 (2018).
51. Cheon, Y.P., Xu, X., Bagchi, M.K. & Bagchi, I.C. Immune-responsive gene 1 is a novel target of progesterone receptor and plays a critical role during implantation in the mouse. Endocrinology 144, 5623-5630 (2003).
52. Zhang, X., Goncalves, R. & Mosser, D.M. The isolation and characterization of murine macrophages. Current protocols in immunology Chapter 14, Unit 14 11 (2008).
53. Gao, J. et al. Absolute quantification of histone PTM marks by MRM-based LC-MS/MS. Anal Chem 86, 9679-9686 (2014).
54. Yu, Y. et al. Quantitative Profiling of Combinational K27/K36 Modifications on Histone H3 Variants in Mouse Organs. J Proteome Res 15, 1070-1079 (2016).
55. Nakagawa, T. et al. CRL4(VprBP) E3 ligase promotes monoubiquitylation and chromatin binding of TET dioxygenases. Molecular cell 57, 247-260 (2015).
56. Ran, F.A. et al. Genome engineering using the CRISPR-Cas9 system. Nat Protoc 8, 2281-2308 (2013).
57. Lee, M., Zhou, Y. & Huang, Y. An Engineered Split-TET2 Enzyme for Chemical-inducible DNA Hydroxymethylation and Epigenetic Remodeling. J Vis Exp (2017).
58. Lv, L. et al. Vpr Targets TET2 for Degradation by CRL4(VprBP) E3 Ligase to Sustain IL-6 Expression and Enhance HIV-1 Replication. Molecular cell 70, 961-970 e965 (2018).
59. Shen, L. et al. Genome-wide analysis reveals TET- and TDG-dependent 5-methylcytosine oxidation dynamics. Cell 153, 692-706 (2013).
60. Liao, Y., Smyth, G.K. & Shi, W. The R package Rsubread is easier, faster, cheaper and better for alignment and quantification of RNA sequencing reads. Nucleic acids research 47, e47 (2019).
61. Chen, L.L. et al. SNIP1 Recruits TET2 to Regulate c-MYC Target Genes and Cellular DNA Damage Response. Cell Rep 25, 1485-1500 e1484 (2018).
62. Lan, F. et al. Recognition of unmethylated histone H3 lysine 4 links BHC80 to LSD1-mediated gene repression. Nature 448, 718-722 (2007).
63. Mikawa, K., Nishina, K., Takao, Y. & Obara, H. ONO-1714, a nitric oxide synthase inhibitor, attenuates endotoxin-induced acute lung injury in rabbits. Anesthesia and analgesia 97, 1751-1755 (2003).